Pharmacodynamic methods for investigating antiasthma drugs in healthy volunteers
- PMID: 9604856
- DOI: 10.1358/mf.1998.20.2.485652
Pharmacodynamic methods for investigating antiasthma drugs in healthy volunteers
Abstract
The investigation of bronchoactive drugs in healthy volunteers may be divided into studies on the drug effects on basal airway calibre, the effects on induced bronchoconstriction and the examination of the pharmacokinetic and side effect profile of new chemical entities. In the studies presented in this paper, whole body plethysmography was used to assess the pharmacological activity of three new development compounds. In the first example, bronchodilatation was measured after administration of an anticholinergic drug. In two further examples, the bronchial effects were studied in asthma models in which an increase in airflow resistance was produced using inhaled methacholine and platelet activating factor (PAF). The method applied in these tests allowed the antagonistic effects of drugs on the constrictor effect of individual agents to be followed. Antiasthmatic drugs can also have a systemic effect on different physiological and biochemical parameters. These parameters can be applied as useful tools in the determination of the pharmacological activity of a given drug, irrespective of the conventional methods used to evaluate the efficacy of bronchodilators by the degree of bronchial muscular relaxation. A complex nonbronchial model is shown in order to demonstrate how it is possible to identify the pharmacologically effective dose of a new beta 2-adrenoceptor agonist.
Similar articles
-
Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses.Eur Respir J. 1996 Mar;9(3):449-55. doi: 10.1183/09031936.96.09030449. Eur Respir J. 1996. PMID: 8730003 Clinical Trial.
-
Apafant (a PAF receptor antagonist) suppresses the early and late airway responses in guinea pigs: a comparison with antiasthmatic drugs.Eur J Pharmacol. 1997 Jun 5;328(1):75-81. doi: 10.1016/s0014-2999(97)83031-2. Eur J Pharmacol. 1997. PMID: 9203572
-
Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism.Chest. 2000 Aug;118(2):321-8. doi: 10.1378/chest.118.2.321. Chest. 2000. PMID: 10936119 Clinical Trial.
-
Beyond the dogma: novel beta2-adrenoceptor signalling in the airways.Eur Respir J. 2006 Jun;27(6):1286-306. doi: 10.1183/09031936.06.00112605. Eur Respir J. 2006. PMID: 16772391 Review.
-
Pharmacogenomics of beta2-agonist: key focus on signaling pathways.Pharmacogenomics. 2006 Sep;7(6):919-33. doi: 10.2217/14622416.7.6.919. Pharmacogenomics. 2006. PMID: 16981850 Review.
Cited by
-
Pharmacokinetics and safety of olodaterol administered with the Respimat Soft Mist inhaler in subjects with impaired hepatic or renal function.Int J Chron Obstruct Pulmon Dis. 2016 Mar 18;11:585-95. doi: 10.2147/COPD.S94234. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27051282 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources